David James Vaughan - Net Worth and Insider Trading
David James Vaughan Net Worth
The estimated net worth of David James Vaughan is at least $15,488 dollars as of 2024-09-21. David James Vaughan is the Senior Officer of Antibe Therapeutics Inc and owns about 52,500 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $15,488. Details can be seen in David James Vaughan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David James Vaughan has not made any transactions after 2020-09-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David James Vaughan
David James Vaughan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David James Vaughan owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .
Click here to see the complete history of David James Vaughan’s form 4 insider trades.
Insider Ownership Summary of David James Vaughan
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:ATE | Antibe Therapeutics Inc | 2020-09-24 | Senior Officer |
David James Vaughan Latest Holdings Summary
David James Vaughan currently owns a total of 1 stock. David James Vaughan owns 52,500 shares of Antibe Therapeutics Inc (TSX:ATE) as of September 24, 2020, with a value of $15,488.
Latest Holdings of David James Vaughan
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:ATE | Antibe Therapeutics Inc | 2020-09-24 | 52,500 | 0.30 | 15,488 |
Holding Weightings of David James Vaughan
David James Vaughan Form 4 Trading Tracker
According to the SEC Form 4 filings, David James Vaughan has made a total of 3 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 52,500 shares on September 24, 2020, which cost David James Vaughan around $175,875.
Insider Trading History of David James Vaughan
- 1
David James Vaughan Trading Performance
GuruFocus tracks the stock performance after each of David James Vaughan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David James Vaughan is 9.25%. GuruFocus also compares David James Vaughan's trading performance to market benchmark return within the same time period. The performance of stocks bought by David James Vaughan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David James Vaughan's insider trading performs compared to the benchmark.
Performance of David James Vaughan
David James Vaughan Ownership Network
David James Vaughan Owned Company Details
What does Antibe Therapeutics Inc do?
Who are the key executives at Antibe Therapeutics Inc?
David James Vaughan is the Senior Officer of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Scott Wilson Curtis .
Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antibe Therapeutics Inc Insider Transactions
David James Vaughan Mailing Address
Above is the net worth, insider trading, and ownership report for David James Vaughan. Currently GuruFocus does not have mailing address information for David James Vaughan.